AUS
NZ
UK
CA
USA
IND
Healthcare
Orthocell Boosts Cash Position Within All Ordinaries Healthcare Segment
February 18, 2026 04:58 PM AEDT| By SamOrthocell strengthens liquidity after receiving a research and development tax refund, supporting regenerative medicine programs within the All Ordinaries healthcare segment.
Cyclopharm Gains NIH Nod, Expands US Technegas Reach
February 18, 2026 04:57 PM AEDT| By SamCyclopharm secures NIH approval for Technegas, strengthening its US expansion strategy, broadening clinical applications, and supporting federal healthcare adoption while advancing innovation and market presence in respiratory imaging solutions.
(ASX:PME) Half-Year Update Draws Focus Across ASX 200 Healthcare Sector
February 18, 2026 04:15 PM AEDT| By Sam(ASX:PME) reports solid half-year financial performance, reinforcing healthcare technology representation within ASX 200 and All Ordinaries indices.
Australian Clinical Labs (ASX:ACL) Faces Margin Pressure Within All Ordinaries Healthcare Segment
February 17, 2026 09:39 PM AEDT| By SamAustralian Clinical Labs reports margin compression amid shifting testing volumes, reflecting evolving dynamics within the All Ordinaries healthcare sector.
Botanix Pharma Strengthens Supply and Sofdra Expansion
February 17, 2026 08:40 PM AEDT| By SamBotanix Pharmaceuticals strengthens its supply chain and Sofdra growth strategy through a major capital raise, focusing on API sourcing, commercial expansion, and operational resilience in the evolving healthcare market.
Sonic Healthcare Shares: Value Outlook for the Year Ahead
February 17, 2026 05:37 PM AEDT| By SamA detailed look at Sonic Healthcare’s valuation outlook, covering financial performance, revenue trends, debt structure, and key metrics shaping its position within the ASX stock market and global healthcare diagnostics industry.
CSL Earnings Insight: Why Results Tell a Deeper Story
February 17, 2026 05:00 PM AEDT| By SamCSL Limited earnings analysis explores unusual expenses, underlying performance strength, and future outlook within the Australian stock market, offering insights into business fundamentals and financial trends.
Healthcare Leader CSL (ASX:CSL) Expands Global Presence Within ASX 20 & ASX 200
February 17, 2026 04:45 PM AEDT| By SamCSL’s biotechnology operations span plasma therapies, vaccines, and global research, reinforcing its presence across key Australian market indices and the healthcare sector.
Why Botanix’s Capital Reset Is Reshaping Market Confidence
February 17, 2026 10:53 AM AEDT| By SamBotanix’s capital reset triggered sharp market recalibration, highlighting dilution dynamics, supply chain priorities, and the delicate balance between short-term volatility and long-term operational stability.
Cochlear Slides After HY Update Shakes Market Mood
February 16, 2026 05:51 PM AEDT| By SamCochlear’s half-year result prompts share price pressure as profit softens. The company advances its Nexa system rollout while strengthening services, adult referrals and global hearing implant access.
ASX 200 Spotlight: Cochlear Dividend Update That Demands Attention
February 16, 2026 01:37 PM AEDT| By SamCochlear’s dividend update highlights the balance between earnings growth and distribution discipline, offering valuable perspective on income dynamics within Australia’s evolving equity market.
Oneview Healthcare Faces Margin Test Amid Growth
February 13, 2026 08:36 PM AEDT| By SamOneview Healthcare posts stronger revenue but wider losses, raising margin and valuation questions. A closer look at growth outlook, funding risks and how the stock compares across the ASX landscape.
COH in Focus as ASX 200 Index Retreats Amid Pressure Across Tech and Healthcare
February 13, 2026 08:16 PM AEDT| By SamASX 200 declines as healthcare and technology stocks, including COH (ASX:COH), weigh on sentiment. Broader indices mirror cautious tone across Australian equities.
Mesoblast Ryoncil Update Drives Adult Trial Focus
February 13, 2026 08:14 PM AEDT| By SamMesoblast advances its adult Ryoncil program following encouraging clinical data, reinforcing its growth roadmap and strengthening its standing within the ASX stock market healthcare segment.
ASX 100 Update: Pro Medicus Margin Profile Draws Attention Across All Ordinaries
February 13, 2026 07:26 PM AEDT| By SamPro Medicus reported an exceptionally strong net margin, reinforcing its healthcare technology position within the ASX 200 and All Ordinaries.
ASX Health Stocks Tumble on ASX Live Amid Intense Reporting Season Volatility
February 13, 2026 04:50 PM AEDT| By SamASX health stocks faced heightened volatility during reporting season, with major names influencing ASX 200 and broader indices amid earnings-driven market movements.
ASX 200 Slides as Tech Weakens and Cochlear Drops Across All Ordinaries
February 13, 2026 02:46 PM AEDT| By SamASX benchmarks retreated at midday as technology stocks weakened and Cochlear recorded sharp movement within the healthcare sector.
ASX 200 Healthcare Volatility Emerges as Pro Medicus Shares Retreat After HY Result
February 13, 2026 01:37 PM AEDT| By SamPro Medicus shares declined following its half-year earnings release, influencing ASX 200 and All Ordinaries healthcare sector performance during reporting season.
ASX 200 Healthcare Reaction Deepens as Pro Medicus Shares Retreat After HY Result
February 13, 2026 01:29 PM AEDT| By SamPro Medicus shares declined following its half-year result, influencing trading within the ASX 200 and broader All Ordinaries healthcare technology sector.
ASX 200 Watch: Why Cochlear’s Latest Update Sparked Debate
February 13, 2026 12:26 PM AEDT| By SamCochlear’s recent update highlighted how earnings quality, product mix, and cash discipline shape sentiment for established healthcare leaders within Australia’s evolving share market.
Advertise your brand on Kalkine Media